Cefoperazone-Sulbactam Pediatric Dosing
The recommended pediatric dose of cefoperazone-sulbactam is 50 mg/kg every 12 hours (100 mg/kg/day divided into 2 doses) administered by intravenous infusion, with doses up to 80 mg/kg/day used for severe infections.
Standard Dosing Regimen
Based on multiple pediatric studies, the established dosing parameters are:
- Mild to moderate infections: 50-80 mg/kg/day divided every 12 hours 1, 2, 3
- Severe infections/sepsis: Up to 80-100 mg/kg/day divided every 12 hours 2, 4
- Route: Intravenous infusion (typically over 30-60 minutes) or IV bolus injection 3, 5
Age-Specific Considerations
Neonates and Infants (<1 month)
- 50 mg/kg every 12 hours is effective for term neonates when targeting common pathogens with MIC ≤1 mg/L 6
- Use caution as safety data in premature infants and neonates are limited
Infants and Children (1 month to 18 years)
- 37.5-50 mg/kg every 12 hours achieves adequate pharmacodynamic targets (50% fT>MIC) for pathogens with MIC ≤0.25 mg/L 6
- 50-80 mg/kg/day in 3-4 divided doses has been used successfully in clinical practice 2, 3, 4
- For severe infections including pneumonia and sepsis, doses up to 80-100 mg/kg/day are appropriate 2, 4
Pharmacokinetic Profile in Children
The drug demonstrates predictable pharmacokinetics in pediatric patients 1:
- Half-life: Cefoperazone 3.6 hours, Sulbactam 1.77 hours
- Peak levels achieved within 5-15 minutes after IV bolus
- Dose-proportional response observed across pediatric age groups 3
Clinical Efficacy Data
Clinical studies demonstrate:
- Clinical success rate: 72-100% across various pediatric infections 2, 3, 4, 5
- Effective coverage: Achieves >90% probability of target attainment at MICs ≤16 μg/mL 1
- Optimal ratio: 1:1 ratio of cefoperazone to sulbactam appears most suitable for pediatric sepsis 1
Administration Guidelines
- Frequency: Every 12 hours is standard; some protocols use every 6-8 hours for severe infections 2
- Infusion time: 30-60 minutes for IV drip, or slow IV bolus over 3-5 minutes 3, 5
- Duration: Typically 3-11 days depending on infection severity and clinical response 2
Important Caveats
- Renal adjustment: Dose reduction required in renal impairment (follow general cephalosporin guidelines)
- Therapeutic drug monitoring: Consider in critically ill patients or those not responding to standard doses 1
- MIC considerations: Efficacy demonstrated for pathogens with MIC ≤32 mg/L; higher MICs may require alternative therapy 7
- Beta-lactamase producers: Particularly effective against beta-lactamase producing organisms including ESBL-producers 3, 4, 7
The evidence consistently supports 50 mg/kg every 12 hours as the foundational pediatric dose, with flexibility to increase to 80-100 mg/kg/day for severe infections while maintaining safety and efficacy.